Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kineta Inc (KA)

Kineta Inc (KA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,687
  • Shares Outstanding, K 10,962
  • Annual Sales, $ 5,440 K
  • Annual Income, $ -14,100 K
  • 60-Month Beta 0.52
  • Price/Sales 1.29
  • Price/Cash Flow N/A
  • Price/Book 2.17
Trade KA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.31
  • Most Recent Earnings $-0.19 on 03/21/24
  • Latest Earnings Date 05/09/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3339 +75.35%
on 04/16/24
0.7399 -20.87%
on 04/22/24
+0.0602 (+11.46%)
since 03/28/24
3-Month
0.3339 +75.35%
on 04/16/24
2.8300 -79.31%
on 02/16/24
-2.0245 (-77.57%)
since 01/29/24
52-Week
0.3339 +75.35%
on 04/16/24
5.3900 -89.14%
on 10/03/23
-3.3845 (-85.25%)
since 04/28/23

Most Recent Stories

More News
Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board

/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Board of Directors has...

PHAR : 9.91 (+1.12%)
KA : 0.5855 (-4.02%)
APRE : 5.08 (-2.22%)
XFOR : 1.0900 (-6.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Kineta, Inc. is a clinical-stage biotechnology company. It develops next-generation immunotherapies that address the major challenges with current cancer therapy. The company's lead asset is KVA12123, a novel VISTA blocking immunotherapy. Kineta merged with Yumanity Therapeutics, Inc., and is based...

See More

Key Turning Points

3rd Resistance Point 0.6327
2nd Resistance Point 0.6232
1st Resistance Point 0.6044
Last Price 0.5855
1st Support Level 0.5761
2nd Support Level 0.5666
3rd Support Level 0.5478

See More

52-Week High 5.3900
Fibonacci 61.8% 3.4586
Fibonacci 50% 2.8619
Fibonacci 38.2% 2.2653
Last Price 0.5855
52-Week Low 0.3339

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar